These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 10362804)

  • 1. Immunohistological analysis of in situ expression of mycobacterial antigens in skin lesions of leprosy patients across the histopathological spectrum. Association of Mycobacterial lipoarabinomannan (LAM) and Mycobacterium leprae phenolic glycolipid-I (PGL-I) with leprosy reactions.
    Verhagen C; Faber W; Klatser P; Buffing A; Naafs B; Das P
    Am J Pathol; 1999 Jun; 154(6):1793-804. PubMed ID: 10362804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential monitoring of leprosy patients with serum antibody levels to phenolic glycolipid-I, a synthetic analog of phenolic glycolipid-I, and mycobacterial lipoarabinomannan.
    Meeker HC; Schuller-Levis G; Fusco F; Giardina-Becket MA; Sersen E; Levis WR
    Int J Lepr Other Mycobact Dis; 1990 Sep; 58(3):503-11. PubMed ID: 2205685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum antibodies to defined carbohydrate antigens during the course of treated leprosy.
    Gelber RH; Li F; Cho SN; Byrd S; Rajagopalan K; Brennan PJ
    Int J Lepr Other Mycobact Dis; 1989 Dec; 57(4):744-51. PubMed ID: 2681457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production and characterization of peptide mimotopes of phenolic glycolipid-I of Mycobacterium leprae.
    Youn JH; Myung HJ; Liav A; Chatterjee D; Brennan PJ; Choi IH; Cho SN; Shin JS
    FEMS Immunol Med Microbiol; 2004 May; 41(1):51-7. PubMed ID: 15094167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody response to phenolic glycolipid I and Mycobacterium w antigens and its relation to bacterial load in M. leprae-infected mice and leprosy patients.
    Moudgil KD; Gupta SK; Naraynan PR; Srivastava LM; Mishra RS; Talwar GP
    Clin Exp Immunol; 1989 Nov; 78(2):214-8. PubMed ID: 12412751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Operational value of serological measurements in multibacillary leprosy patients: clinical and bacteriological correlates of antibody responses.
    Roche PW; Britton WJ; Failbus SS; Williams D; Pradhan HM; Theuvenet WJ
    Int J Lepr Other Mycobact Dis; 1990 Sep; 58(3):480-90. PubMed ID: 2205683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of measuring serum levels of anti-PGL-I antibody, neopterin and C-reactive protein in monitoring leprosy patients during multi-drug treatment and reactions.
    Silva EA; Iyer A; Ura S; Lauris JR; Naafs B; Das PK; Vilani-Moreno F
    Trop Med Int Health; 2007 Dec; 12(12):1450-8. PubMed ID: 18076551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of recombinant serine-rich 45-kDa antigen (ML0411) for detection of antibodies in leprosy patients.
    Parkash O; Kumar A; Nigam A; Franken KL; Ottenhoff TH
    Scand J Immunol; 2006 Oct; 64(4):450-5. PubMed ID: 16970689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression profile of Rab5, Rab7, tryptophan aspartate-containing coat protein, leprae lipoarabinomannan, and phenolic glycolipid-1 on the failure of the phagolysosome process in macrophages of leprosy patients as a viability marker of Mycobacterium leprae.
    Prakoeswa CR; Wahyuni R; Iswahyudi ; Adriaty D; Yusuf I; Sutjipto ; Agusni I; Izumi S
    Int J Mycobacteriol; 2016 Jun; 5(2):155-63. PubMed ID: 27242226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of antibody responses to Mycobacterium leprae phenolic glycolipid I, lipoarabinomannan, and recombinant proteins to define disease subtype-specific antigenic profiles in leprosy.
    Spencer JS; Kim HJ; Wheat WH; Chatterjee D; Balagon MV; Cellona RV; Tan EV; Gelber R; Saunderson P; Duthie MS; Reece ST; Burman W; Belknap R; Mac Kenzie WR; Geluk A; Oskam L; Dockrell HM; Brennan PJ;
    Clin Vaccine Immunol; 2011 Feb; 18(2):260-7. PubMed ID: 21177913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody response to recombinant 65-kDa, 70-kDa and 18-kDa mycobacterial antigens in leprosy patients and healthy contacts in a leprosy-endemic population.
    Ilangumaran S; Shankernarayan N; Ramu G; Muthukkaruppan V
    Int J Lepr Other Mycobact Dis; 1994 Jun; 62(2):245-55. PubMed ID: 7519226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of anti-PGL-1, anti-35 kDa and anti-lipoarabinomannan assays for serodiagnosis of leprosy.
    Jayapal V; Selvibai G; Mahalakshmi K; Pushkala ; Regunath K; Subramanian S
    Indian J Lepr; 2001; 73(3):229-37. PubMed ID: 11840595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Lipoarabinomannan-Specific Salivary IgA as Prognostic Marker for Leprosy Reactions in Patients and Cellular Immunity in Contacts.
    Nahas AA; Lima MIS; Goulart IMB; Goulart LR
    Front Immunol; 2018; 9():1205. PubMed ID: 29904387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum IgA1 and IgM antibodies against Mycobacterium leprae-derived phenolic glycolipid-I: a comparative study in leprosy patients and their contacts.
    Chujor CS; Bernheimer H; Levis WR; Schwerer B
    Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):441-9. PubMed ID: 1890368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PGL-I antigen and antibody detection in leprosy patients: evolution under chemotherapy.
    Chanteau S; Cartel JL; Celerier P; Plichart R; Desforges S; Roux J
    Int J Lepr Other Mycobact Dis; 1989 Dec; 57(4):735-43. PubMed ID: 2681456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serologic responses to Mycobacterium leprae-specific phenolic glycolipid-I antigen in sooty mangabey monkeys with experimental leprosy.
    Gormus BJ; Ohashi DK; Ohkawa S; Walsh GP; Meyers WM; Brennan PJ; Trygg C
    Int J Lepr Other Mycobact Dis; 1988 Dec; 56(4):537-45. PubMed ID: 2464657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A serologic study of naturally acquired leprosy in chimpanzees.
    Gormus BJ; Xu KY; Alford PL; Lee DR; Hubbard GB; Eichberg JW; Meyers WM
    Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):450-7. PubMed ID: 1890369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgM antibodies to native phenolic glycolipid-I in contacts of leprosy patients in Venezuela: epidemiological observations and a prospective study of the risk of leprosy.
    Ulrich M; Smith PG; Sampson C; Zuniga M; Centeno M; Garcia V; Manrique X; Salgado A; Convit J
    Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):405-15. PubMed ID: 1890364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to phenolic glycolipid-1 and to whole Mycobacterium leprae in leprosy patients: evolution during therapy.
    Bach MA; Wallach D; Flageul B; Hoffenbach A; Cottenot F
    Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):256-67. PubMed ID: 3522769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of Mycobacterium leprae phenolic glycolipid I (PGL-I) in serodiagnosis and in the pathogenesis of leprosy.
    Spencer JS; Brennan PJ
    Lepr Rev; 2011 Dec; 82(4):344-57. PubMed ID: 22439275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.